SG11201809400UA - Purification method for pancreatic precursor cells derived from pluripotent stem cells and amplification method therefor - Google Patents
Purification method for pancreatic precursor cells derived from pluripotent stem cells and amplification method thereforInfo
- Publication number
- SG11201809400UA SG11201809400UA SG11201809400UA SG11201809400UA SG11201809400UA SG 11201809400U A SG11201809400U A SG 11201809400UA SG 11201809400U A SG11201809400U A SG 11201809400UA SG 11201809400U A SG11201809400U A SG 11201809400UA SG 11201809400U A SG11201809400U A SG 11201809400UA
- Authority
- SG
- Singapore
- Prior art keywords
- pluripotent stem
- stem cells
- pancreatic progenitor
- cells derived
- cells
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 11
- 210000001778 pluripotent stem cell Anatomy 0.000 title abstract 6
- 230000003321 amplification Effects 0.000 title abstract 2
- 210000004027 cell Anatomy 0.000 title abstract 2
- 238000003199 nucleic acid amplification method Methods 0.000 title abstract 2
- 239000002243 precursor Substances 0.000 title abstract 2
- 238000000746 purification Methods 0.000 title abstract 2
- 210000000130 stem cell Anatomy 0.000 abstract 6
- 102000018233 Fibroblast Growth Factor Human genes 0.000 abstract 2
- 108050007372 Fibroblast Growth Factor Proteins 0.000 abstract 2
- 238000012258 culturing Methods 0.000 abstract 2
- 229940126864 fibroblast growth factor Drugs 0.000 abstract 2
- 210000004153 islets of langerhan Anatomy 0.000 abstract 2
- FABQUVYDAXWUQP-UHFFFAOYSA-N N4-(1,3-benzodioxol-5-ylmethyl)-6-(3-methoxyphenyl)pyrimidine-2,4-diamine Chemical compound COC1=CC=CC(C=2N=C(N)N=C(NCC=3C=C4OCOC4=CC=3)C=2)=C1 FABQUVYDAXWUQP-UHFFFAOYSA-N 0.000 abstract 1
- 230000004069 differentiation Effects 0.000 abstract 1
- 230000008014 freezing Effects 0.000 abstract 1
- 238000007710 freezing Methods 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
- C12N5/0678—Stem cells; Progenitor cells; Precursor cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
- C12N5/0677—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0062—General methods for three-dimensional culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/113—Acidic fibroblast growth factor (aFGF, FGF-1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/117—Keratinocyte growth factors (KGF-1, i.e. FGF-7; KGF-2, i.e. FGF-12)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/119—Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/415—Wnt; Frizzeled
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/72—Transferases (EC 2.)
- C12N2501/727—Kinases (EC 2.7.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Developmental Biology & Embryology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016091116 | 2016-04-28 | ||
| PCT/JP2017/016728 WO2017188378A1 (ja) | 2016-04-28 | 2017-04-27 | 多能性幹細胞由来膵前駆細胞の純化法とその増幅法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201809400UA true SG11201809400UA (en) | 2018-11-29 |
Family
ID=60159764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201809400UA SG11201809400UA (en) | 2016-04-28 | 2017-04-27 | Purification method for pancreatic precursor cells derived from pluripotent stem cells and amplification method therefor |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20190136197A1 (ja) |
| EP (1) | EP3450541A4 (ja) |
| JP (1) | JP7055740B2 (ja) |
| KR (1) | KR102257868B1 (ja) |
| CN (1) | CN109415689A (ja) |
| AU (1) | AU2017255099B2 (ja) |
| CA (1) | CA3022365A1 (ja) |
| EA (1) | EA201892447A1 (ja) |
| IL (1) | IL262554A (ja) |
| MX (1) | MX2018013175A (ja) |
| SG (1) | SG11201809400UA (ja) |
| TW (1) | TWI710636B (ja) |
| WO (1) | WO2017188378A1 (ja) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2020527956A (ja) * | 2017-07-21 | 2020-09-17 | センマ・セラピューティクス・インコーポレーテッド | 幹細胞由来の膵臓ベータ細胞の再凝集 |
| JPWO2020080550A1 (ja) * | 2018-10-15 | 2021-10-14 | エヴィア ライフ サイエンシズ インコーポレイテッド | 低分子化合物による内胚葉組織又は器官由来細胞からの幹／前駆細胞の作製方法 |
| CN109749986B (zh) * | 2019-03-13 | 2021-04-02 | 武汉大学 | 一种由人多能干细胞分化获得胰腺前体细胞及胰岛β细胞的方法 |
| CN112961823B (zh) * | 2021-03-19 | 2024-01-23 | 上海爱萨尔生物科技有限公司 | 一种诱导多能干细胞定向分化制备胰岛β细胞的培养液 |
| CN112980774B (zh) * | 2021-03-19 | 2022-04-01 | 上海爱萨尔生物科技有限公司 | 一种诱导多能干细胞定向分化制备胰岛β细胞的培养方法 |
| CN113046299A (zh) * | 2021-03-19 | 2021-06-29 | 上海爱萨尔生物科技有限公司 | 一种诱导多能干细胞定向分化制备胰岛β细胞的添加剂 |
| CN113234664B (zh) * | 2021-05-11 | 2024-05-10 | 澳门大学 | 一种胰腺祖细胞的制备方法及其应用 |
| CN115011544B (zh) * | 2022-05-30 | 2023-11-17 | 广州国家实验室 | 体外诱导获得胰岛δ细胞的方法及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5579281A (en) | 1978-11-28 | 1980-06-14 | Nippon Oil Co Ltd | Rainnproof construction of floatinggroof tank |
| DK2421957T3 (da) * | 2009-04-22 | 2021-01-25 | Viacyte Inc | Cellesammensætninger afledt af dedifferentierede omprogrammerede celler |
| EP2857500B1 (en) * | 2012-05-25 | 2018-01-31 | Saitama Medical University | Method for producing pancreatic hormone-producing cell, pancreatic hormone-producing cell, and differentiation/induction promoter |
| JP2014161257A (ja) * | 2013-02-22 | 2014-09-08 | Univ Of Tokyo | 多能性幹細胞から膵ランゲルハンス島を製造する方法 |
| US10266807B2 (en) * | 2013-04-03 | 2019-04-23 | FUJIFILM Cellular Dynamics, Inc. | Methods and compositions for culturing endoderm progenitor cells in suspension |
| WO2015013653A1 (en) * | 2013-07-26 | 2015-01-29 | The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone | Generating definitive endoderm and pancreatic progenitor cells |
| JP6678107B2 (ja) * | 2014-08-04 | 2020-04-08 | 武田薬品工業株式会社 | 膵前駆細胞の増殖方法 |
-
2017
- 2017-04-27 US US16/096,855 patent/US20190136197A1/en not_active Abandoned
- 2017-04-27 SG SG11201809400UA patent/SG11201809400UA/en unknown
- 2017-04-27 AU AU2017255099A patent/AU2017255099B2/en not_active Ceased
- 2017-04-27 KR KR1020187034169A patent/KR102257868B1/ko active IP Right Grant
- 2017-04-27 CN CN201780039853.8A patent/CN109415689A/zh active Pending
- 2017-04-27 EP EP17789660.2A patent/EP3450541A4/en not_active Withdrawn
- 2017-04-27 MX MX2018013175A patent/MX2018013175A/es unknown
- 2017-04-27 WO PCT/JP2017/016728 patent/WO2017188378A1/ja active Application Filing
- 2017-04-27 TW TW106114087A patent/TWI710636B/zh not_active IP Right Cessation
- 2017-04-27 JP JP2018514702A patent/JP7055740B2/ja active Active
- 2017-04-27 EA EA201892447A patent/EA201892447A1/ru unknown
- 2017-04-27 CA CA3022365A patent/CA3022365A1/en active Pending
-
2018
- 2018-10-24 IL IL262554A patent/IL262554A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20190136197A1 (en) | 2019-05-09 |
| KR20180136544A (ko) | 2018-12-24 |
| MX2018013175A (es) | 2019-02-21 |
| EA201892447A1 (ru) | 2019-04-30 |
| KR102257868B1 (ko) | 2021-05-27 |
| CA3022365A1 (en) | 2017-11-02 |
| AU2017255099A1 (en) | 2018-11-22 |
| TWI710636B (zh) | 2020-11-21 |
| TW201800576A (zh) | 2018-01-01 |
| CN109415689A (zh) | 2019-03-01 |
| IL262554A (en) | 2018-12-31 |
| JP7055740B2 (ja) | 2022-04-18 |
| EP3450541A4 (en) | 2019-11-13 |
| WO2017188378A1 (ja) | 2017-11-02 |
| JPWO2017188378A1 (ja) | 2019-04-04 |
| EP3450541A1 (en) | 2019-03-06 |
| AU2017255099B2 (en) | 2021-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201809400UA (en) | Purification method for pancreatic precursor cells derived from pluripotent stem cells and amplification method therefor | |
| PH12016502274A1 (en) | Use of small molecules to enhance mafa expression in pancreatic endocrine cells | |
| PH12015501465A1 (en) | Culturing of human embryonic stem cells at the air-liquid interface for differentiation into pancreatic endocrine cells | |
| WO2012135621A3 (en) | Priming of pluripotent stem cells for neural differentiation | |
| AU2017254264A1 (en) | Method for producing retinal tissue | |
| MY188836A (en) | Method for manufacturing telencephalon or progenitor tissue thereof | |
| AU2018260810A1 (en) | Defined media for expansion and maintenance of pluripotent stem cells | |
| CA2909230C (en) | Method for inducing alveolar epithelial progenitor cells | |
| MX343462B (es) | Medio del cultivo celular. | |
| WO2015054526A3 (en) | Methods of mammalian retinal stem cell production and applications | |
| NZ622427A (en) | Multipotent stem cells from the extrahepatic biliary tree and methods of isolating same | |
| MX356756B (es) | Células madre pluripotentes en microportadores. | |
| SG195299A1 (en) | Expansion of stem cells in hollow fiber bioreactors | |
| EP2408903A4 (en) | PLURIPOTENTE AND MULTIPOTENTE CELL CULTURE ON MICROWAVES | |
| WO2016061071A8 (en) | Generation of keratinocytes from pluripotent stem cells and maintenance of keratinocyte cultures | |
| EP1904624A4 (en) | METHOD FOR THE CULTIVATION AND REPRODUCTION OF HEMATOPOETIC STEM CELLS AND PRECURSOR CELLS USING HUMAN ENDOMETRIUM CELLS | |
| EP2504425A4 (en) | DIFFERENTIATION OF HUMAN EMBRYONIC AND INDUCED PLURIPOTENTER STEM CELLS | |
| MY189592A (en) | Method for producing cerebellar progenitor tissue | |
| WO2018138281A8 (en) | Pluripotent stem cells | |
| EP3892719A4 (en) | UNDIFFERENTIATED STATE-MAINTAINING CULTURE MEDIUM FOR PLURIPOTENTIC STEM CELLS | |
| JP2015213495A5 (ja) | ||
| MX2021014681A (es) | Células progenitoras de oligodendrocitos inducidas por la caja hmg relacionada con sry 9. | |
| EP4004191A4 (en) | PROGENITORS OF MESENCHYMAL STEM CELLS DERIVED FROM INDUCED PLURIPOTENTIC STEM CELLS AND METHODS OF PRODUCTION THE SAME | |
| EA201501002A1 (ru) | Способ культивирования гепатобластподобных клеток и продукт их культивирования | |
| IL285083A (en) | Culture media for pluripotent stem cells |